The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker
Aug 2, 2026 · 49 min · 14 segments
Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy…
Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy people understand what to change before disease develops. Some thought he was crazy. That idea became InsideTracker, the company he founded 17 years ago, which brings together blood biomarkers, genetic information and wearable data to give people personalised recommendations for improving their health. In this conversation, Dr Blander traces the scientific journey that took him from the Weizmann Institute to MIT and eventually to founding InsideTracker. He explains what he learned from some of the early breakthroughs in longevity research, why collecting more health data is not enough if people do not act on it, and why he believes behaviour change may now be one of the biggest challenges in extending healthy life. We also discuss his recent decision to step back from his operational role at InsideTracker and what he describes as his “second career”: taking personalised, preventative health beyond the longevity community and making it relevant to a much wider population. Guest Bio Dr Gil Blander is the founder of InsideTracker, a personalised health and longevity platform that combines blood biomarkers, DNA and wearable data to generate individualised health recommendations. He trained as a scientist at the Weizmann Institute, where he worked with Professor Moshe Oren on p53 and cancer biology, before moving to MIT to join Professor Leonard Guarente’s laboratory during an important period in the study of genes associated with ageing and longevity. After 17 years leading InsideTracker, Dr Blander recently stepped back from his operational role to focus on bringing personalised and preventative health to a much broader population. About Dr Gil Blander > Principal: Healthspan Strategies Advisors and Founder and CEO of Stealth Health Tech startup \* Instagram: Founder of @insidetracker \* Instagram: Host of @beyond\_healthspan\_podcast \* LinkedIn: linkedin.com/in/gilblander \* Company: insidetracker.com \* Longevity by Design: info.insidetracker.com/longevitybydesign Episode Chapters \* 00:00 Welcome and Guest Introduction \* 03:07 Why Data Alone Does Not Change Health \* 05:02 Different People Need Different Motivation \* 07:01 The Scientific Roots at Weizmann \* 11:50 Inside MIT’s Early Longevity Research \* 13:24 Leaving Academia for Industry \* 16:04 The Idea Behind InsideTracker \* 19:25 How InsideTracker Works \* 20:35 Why Blood, DNA and Wearables Work Better Together \* 26:14 Why Behaviour Change May Be the Real Frontier \* 27:48 Taking Longevity Beyond the Longevity Bubble \* 30:43 What Actually Makes Healthy Habits Stick \* 34:58 What Real-World Data Can Teach Us \* 40:29 Stepping Back and Starting a “Second Career” \* 42:05 Longevity Hype, Science and the Limits of What We Know \* 44:27 Rapid Fire \* 47:20 Final Takeaways
Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy…
- Show signals
- BiasNot political
